Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST).

@article{Hohenberger2009NeoadjuvantIA,
  title={Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST).},
  author={Peter Hohenberger and O. Oladeji and Thomas Licht and Antonia Dimitrakopoulou-Strauss and Jens Jakob and Daniel Pink and Matthias Heinrich Martin Schwarzbach and Philip Str{\"o}bel and Peter Reichardt and Eva Wardelmann},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 15_suppl},
  pages={10550}
}
10550 Background: We assessed the outcome of patients with locally advanced gastrointestinal stromal tumors (GIST) undergoing preoperative therapy with imatinib. METHODS 36 patients with biopsy proven GIST (23 f, 13 m, median age 58 (27-85) yrs, 31 primary tumors, 5 local recurrences) of the esophagus/EGJ (n=5), stomach (n=17), duodenum (n=2), small bowel (n=3), or rectum (n=9) were treated with imatinib 400mg/d for 6 mos. preop. Six pts had been found unresectable at exploratory lap. and no… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…